Hormonal disorders are receiving more attention than ever before, and for good reason. Endocrine diseases have a considerable impact on public health and are considered among the leading causes of illness and mortality worldwide.
The rise in diagnoses reflects three different forces happening at the same time: genuine increases in some conditions driven by lifestyle and environmental factors, better testing that identifies cases that were previously missed, and broader diagnostic criteria that classify more people as having a disorder than in the past.
If it feels like everyone is talking about PCOS, thyroid disease, insulin resistance, low testosterone, cortisol imbalance, or perimenopause, you’re not imagining it. The question of why more people are being diagnosed with hormonal disorders has become increasingly common. Diagnosis rates are rising, but the explanation is not the same for every condition.
Some hormonal disorders are becoming more common. Others are being detected more frequently because awareness and testing have improved. Still others are affected by changes in diagnostic definitions. Understanding these differences helps separate real trends from misleading assumptions.
- Hormonal disorder diagnoses are rising because of three factors: more cases of some conditions, better testing and awareness, and broader diagnostic criteria.
- Metabolic disorders such as type 2 diabetes are genuinely increasing. Environmental chemicals like BPA, phthalates, and PFAS may also contribute.
- PCOS and thyroid disorders are diagnosed more often due to improved screening, greater awareness, and expanded definitions, not just higher disease rates.
Read More: Hormones, PCOS, and Hidradenitis Suppurativa: The Hidden Female Risk Factor No One Discusses
Three Reasons Diagnoses Are Rising and Why They Are Not the Same
When hormonal disorder diagnoses increase, three distinct explanations may be operating simultaneously. The first has become more common, as more people have the condition than in previous decades.
Environmental exposures, obesity, dietary patterns, sleep deprivation, and sedentary lifestyles can all contribute to this trend. Type 2 diabetes is one of the clearest examples. The second is better detection. Improved testing, greater physician awareness, and increased patient education mean conditions that once went unnoticed are now being diagnosed more often.
The third is diagnostic expansion, where medical criteria become broader over time. This allows more people to qualify for a diagnosis without necessarily increasing the number of people who actually have clinically significant disease. Most rising hormonal conditions involve a combination of all three factors. Treating them as a single phenomenon oversimplifies the evidence.
The Genuine Increase: Metabolic and Insulin-Related Conditions
The rise of type 2 diabetes over recent decades is well documented. Growing obesity rates, higher consumption of ultra-processed foods, reduced physical activity, and chronic sleep deprivation all contribute to worsening insulin sensitivity. Over time, this increases the likelihood of insulin resistance and type 2 diabetes.
Hyperandrogenism, characterized by excess androgen hormones in women, affects an estimated 6% to 12% of women of reproductive age. Evidence suggests its incidence is increasing as well. Researchers believe the connection between obesity, insulin resistance, and androgen production plays a major role.
These trends suggest that some increases in hormonal disorders are not simply the result of better diagnosis. They reflect genuine shifts in human physiology driven by modern environmental and lifestyle factors.
Endocrine Disruptors: The Environmental Factor With Growing Evidence
One reason discussions about why hormonal disorders are increasing often focus on environmental exposures is the growing research on endocrine-disrupting chemicals, or EDCs. EDCs are substances that interfere with normal hormone signaling. They may mimic hormones, block hormone receptors, or alter hormone production and metabolism.
While the evidence varies depending on the chemical and condition being studied, several associations have become increasingly difficult to ignore. Among the most studied endocrine disruptors are BPA and phthalates. These compounds are commonly found in plastics, food packaging, and personal care products.
Research has linked them to disruptions in thyroid hormone signaling and reproductive hormone regulation. Another group of chemicals attracting significant attention is PFAS, which are associated with hormonal disruption. PFAS, often called “forever chemicals,” are found in non-stick cookware, water-resistant products, food packaging, and contaminated water supplies.
Studies have associated PFAS exposure with thyroid dysfunction and metabolic disturbances. Agricultural pesticide exposure has also been linked to reproductive and endocrine abnormalities in exposed populations.
The Endocrine Society’s 2024 scientific statement identified endocrine disruptors as an important contributor to rising hormonal disorder prevalence, particularly thyroid disease, reproductive disorders, and metabolic dysfunction.
While complete avoidance is unrealistic, reducing exposure to plastic food containers, limiting heavily packaged foods, choosing PFAS-free cookware when possible, and being selective about personal care products may help reduce cumulative exposure.
The Diagnosis Detection Effect: Thyroid Disease and PCOS
Not every increase in diagnosis reflects a true increase in disease. The thyroid disorder diagnosis has increased over recent decades, partly explained by greater testing. Thyroid-stimulating hormone (TSH) testing has become routine in many annual health screenings.
As testing increases, more people with mild or previously undetected thyroid abnormalities are identified. This includes cases of subclinical hypothyroidism overdiagnosis, where TSH levels are elevated, but thyroid hormone levels remain within normal ranges. Some experts continue to debate whether all of these individuals benefit from treatment.
PCOS affects between 4% and 20% of women, depending on the diagnostic criteria used. Symptoms often begin years before diagnosis, and many women remain undiagnosed for extended periods. Greater public awareness has encouraged more women to seek evaluation for irregular periods, acne, excess hair growth, and fertility concerns.
Social media platforms such as TikTok and Instagram have significantly increased awareness of PCOS, thyroid disorders, and hormonal symptoms among younger adults. As a result, more people are being diagnosed today, even if the underlying prevalence has not increased to the same degree.
Chronic Stress and the Cortisol Connection
Modern life has introduced another factor that may contribute to rising hormonal conditions: chronic stress. Long-term psychological stress activates the hypothalamic-pituitary-adrenal (HPA) axis, increasing cortisol production. Elevated cortisol levels can affect multiple hormone systems throughout the body.
Research shows that chronic stress can worsen insulin resistance, interfere with thyroid hormone conversion, disrupt reproductive hormone signaling, and contribute to elevated blood pressure.
The important difference is that these effects are real and measurable. However, the popular wellness concept of “adrenal fatigue” remains unrecognized by mainstream endocrinology and lacks established diagnostic criteria. The connection between cortisol and chronic stress hormones is supported by evidence. The concept of adrenal fatigue is not recognized.
The Diagnostic Expansion Effect: When More Diagnoses Reflect Changed Criteria
Some increases in diagnosis rates are driven partly by changing definitions. PCOS, now increasingly referred to in some literature as polyendocrine metabolic ovarian syndrome (PMOS), provides one of the clearest examples.
Under the original NIH criteria, a diagnosis required both irregular ovulation and signs of excess androgen production. These stricter criteria produced prevalence estimates of roughly 7%. This does not necessarily mean more women developed the condition. It means more women meet the definition.
A similar phenomenon occurred when prediabetes diagnostic thresholds expanded. Lowering the HbA1c cutoff from 6.0% to 5.7% substantially increased the number of people classified as having prediabetes. Understanding these shifts is essential when interpreting trends in hormonal disorder diagnoses.
The Awareness and Testing Boom: Social Media and Wearables
Health information is more accessible than ever before. Social media platforms, wearable devices, fertility tracking apps, and direct-to-consumer health testing have made people more aware of hormonal health. Discussions about perimenopause awareness, diagnosis, menstrual cycles, low testosterone, insulin resistance, and thyroid symptoms have become commonplace.
Wearables now track sleep quality, heart rate variability, temperature changes, and menstrual cycle patterns, encouraging users to pay closer attention to their health. This increased awareness often leads to earlier diagnosis and treatment, which can improve long-term outcomes.
However, it can also contribute to self-diagnosis and anxiety when symptoms are interpreted without proper medical evaluation. Accurate diagnosis requires clinical context.
Read More: Perimenopause vs. PCOS: Overlapping Symptoms You Shouldn’t Ignore
Conclusion
The rise in hormonal disorder diagnoses is real, but the reasons behind it are more complex than many headlines suggest. Some conditions are genuinely becoming more common because of lifestyle and environmental changes. Others are being identified more effectively through better awareness and testing. Still others reflect broader diagnostic criteria rather than a true increase in disease.
Understanding which explanation applies to which condition helps people make informed decisions about testing, treatment, and the lifestyle changes that can significantly improve hormone levels.
Frequently Asked Questions
Q. Are hormonal disorders actually becoming more common, or are they just being diagnosed more?
A. Both. Conditions such as type 2 diabetes and metabolic syndrome are genuinely increasing because of obesity, dietary patterns, sleep disruption, and physical inactivity. PCOS and thyroid disorders are also being diagnosed more often due to improved awareness and testing.
Q. Can environmental chemicals cause hormonal disorders?
A. Yes. Research increasingly supports a role for endocrine disruptors, including BPA, phthalates, and PFAS, in thyroid dysfunction and reproductive hormone disruption. The strength of evidence varies by chemical and condition, but major endocrinology organizations recognize endocrine disruptors as a cause for rising hormonal disorder prevalence alongside lifestyle and metabolic factors.
Q. What can I do if I think I have a hormonal disorder?
A. Start with a medical evaluation rather than relying on social media symptom lists. Depending on your symptoms, your healthcare provider may order TSH testing for thyroid concerns, fasting glucose and HbA1c for metabolic concerns, or a formal hormone panel timed appropriately within the month.
References
- Barker, D. J. P. (2013). The developmental origins of chronic adult disease. Acta Paediatrica, 102(Suppl. 465), 44–47.
- Diamanti-Kandarakis, E., Bourguignon, J. P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2014). Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocrine Reviews, 35(3), 293–342.
- Endocrine Society. (2024). Endocrine-disrupting chemicals: 2024 scientific statement.
- Fitterfly. (n.d.). Type 2 diabetes: A global health crisis impacting productivity. What you need to know.
- Primary Care Dermatology Society. (n.d.). Hyperandrogenism.
- Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Bozdag, G., Escobar-Morreale, H. F., & International PCOS Network. (2024). Polycystic ovary syndrome: Contemporary diagnosis and management. Medical Journal article.
- Yau, T. T., Ng, N. Y. H., Cheung, L. P., Ma, R. C. W., & Chan, J. C. N. (2022). Polycystic ovary syndrome: A common but often underdiagnosed endocrine disorder. Frontiers in Endocrinology, 13, Article 9570268.
In this Article